Terconazole
- Level
- Commodity
- Parent
- 51303400
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51303407This classification denotes an antifungal agent with the molecular formula C26H31CL2N5O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0KJ2VE664U. European Medicines Agency schedules terconazole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10917MIG. The term TERCONAZOLE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 35, no. 5 1981, list 21. ). TERCONAZOLE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule terconazole under HS 29349990 and SITC 51579. As of Q4 2014, TERCONAZOLE remains the US FDA Preferred Term for this commodity. Terconazole bears US NLM identifiers UMLS ID C0076115 and NCI Concept Code C29493. SMILES: CLC1C(C2(OC(CO2)COC2CCC(N3CCN(CC3)C(C)C)CC2)CN2NCNC2)CCC(CL)C1.
Same parent
Under 51303400 · 7Activities that produce or sell this
KBLI · 9Inherited from family 51300000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.